MedTrace Logo

CBG Normalization After Discontinuation of COC's

NCT06802211 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2026-04-22

No results posted yet for this study

Summary

In this study, the investigators aim to examine after which duration corticosteroid-binding globulin (CBG) and total cortisol concentrations return to normal after cessation of the combined oral contraceptive pill in healthy women.

Conditions

  • Combined Oral Contraceptive Cessation

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Annemieke C Heijboer, Prof. Dr. · Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Laboratory Medicine, Endocrine Laboratory, Boelelaan 1117, Amsterdam, The Netherlands

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-05
Primary Completion
2025-11-18
Completion
2025-11-18

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06802211 on ClinicalTrials.gov